Relay Therapeutics, Inc. (RLAY)

NGM – Real Time Price. Currency in USD

19.92

-0.07 (-0.33%)

Market open: Aug 12, 2026, 12:50 PM EDT

20.17

+0.18 (0.90%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

15M

10M

26M

Cost of goods sold

-4M

-5M

-4M

Gross Profit

12M

20M

-3M

Operating expenses (excl. COGS)

-315M

-390M

-400M

-308M

Operating Income

-303M

-386M

-379M

-311M

Non-operating income, total

26M

48M

37M

20M

Pretax income

-276M

-338M

-342M

-291M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-276M

-338M

-342M

-291M

Discontinued operations

Net income

-276M

-338M

-342M

-291M

Dilution adjustment

Preferred dividends

Relay Therapeutics, Inc. (RLAY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Relay Therapeutics, Inc. (RLAY)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Relay Therapeutics, Inc. (RLAY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Relay Therapeutics, Inc. (RLAY)

Income Statement (Annual)

Income Statement (Annual)